Autoantibodies to myelin oligodendrocyte glycoprotein (MOG) in patients with demyelinating diseases of the central nervous system (CNS) : investigation of the clinical spectrum and pathological potential
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
München, Ludwig-Maximilians-Universität, Dissertation, 2017
- Schlagwort
-
Autoantibodies
Patients
Diseases
B cells
Central nervous system
- Ereignis
-
Veröffentlichung
- (wo)
-
München
- (wer)
-
Universitätsbibliothek der Ludwig-Maximilians-Universität
- (wann)
-
2017
- Urheber
-
Spadaro, Melania
- Beteiligte Personen und Organisationen
-
Conradt, Barbara
- URN
-
urn:nbn:de:bvb:19-228106
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Spadaro, Melania
- Conradt, Barbara
- Universitätsbibliothek der Ludwig-Maximilians-Universität
Entstanden
- 2017
Ähnliche Objekte (12)
Autoimmunity against oligodendrocyte myelin glycoprotein (OMGP)
The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody
Relapsing MRI-negative myelitis associated with myelin-oligodendrocyte glycoprotein autoantibodies: a case report
Myelin Oligodendrocyte Glycoprotein as an Autoantigen in Inflammatory Demyelinating Diseases of the Central Nervous System
MRI of the first event in pediatric acquired demyelinating syndromes with antibodies to myelin oligodendrocyte glycoprotein
Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease
Blood parameters in pediatric myelin oligodendrocyte glycoprotein antibody-associated disorders
Sentinel seizure heralding Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease
Cortical atrophy patterns in myelin oligodendrocyte glycoprotein antibody-associated disease
Features of myelin oligodendrocyte glycoprotein (MOG) required for the detection of autoantibodies from patients with MOG-antibody-associated disorders
Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination
Challenging diagnosis of myelin oligodendrocyte glycoprotein (MOG) antibody: positive optic neuritis
Autoimmunity against oligodendrocyte myelin glycoprotein (OMGP)
The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody
Relapsing MRI-negative myelitis associated with myelin-oligodendrocyte glycoprotein autoantibodies: a case report
Myelin Oligodendrocyte Glycoprotein as an Autoantigen in Inflammatory Demyelinating Diseases of the Central Nervous System
MRI of the first event in pediatric acquired demyelinating syndromes with antibodies to myelin oligodendrocyte glycoprotein
Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease
Blood parameters in pediatric myelin oligodendrocyte glycoprotein antibody-associated disorders
Sentinel seizure heralding Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease
Cortical atrophy patterns in myelin oligodendrocyte glycoprotein antibody-associated disease
Features of myelin oligodendrocyte glycoprotein (MOG) required for the detection of autoantibodies from patients with MOG-antibody-associated disorders
Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination
Challenging diagnosis of myelin oligodendrocyte glycoprotein (MOG) antibody: positive optic neuritis
Autoimmunity against oligodendrocyte myelin glycoprotein (OMGP)
The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody
Relapsing MRI-negative myelitis associated with myelin-oligodendrocyte glycoprotein autoantibodies: a case report
Myelin Oligodendrocyte Glycoprotein as an Autoantigen in Inflammatory Demyelinating Diseases of the Central Nervous System
MRI of the first event in pediatric acquired demyelinating syndromes with antibodies to myelin oligodendrocyte glycoprotein
Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease
Blood parameters in pediatric myelin oligodendrocyte glycoprotein antibody-associated disorders
Sentinel seizure heralding Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease
Cortical atrophy patterns in myelin oligodendrocyte glycoprotein antibody-associated disease
Features of myelin oligodendrocyte glycoprotein (MOG) required for the detection of autoantibodies from patients with MOG-antibody-associated disorders
Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination